![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Doba N. Tomiyama H. Nakayama T.
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.14, Iss.3, 1999-03, pp. : 153-163
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prevention and Pharmacovigilance: What Should We Do, What Can We Do?
Drug Safety, Vol. 35, Iss. 2, 2012-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?
By Nosten F.
CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The diabetic heart - what is to blame and what can we do?
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :